Evidence map›Paper›PMID 39360313›Full record

ArticleFrontiers in microbiology2024

GRB7-mediated enhancement of cell malignant characteristics induced by

Huilin Zhao, Si Chen, Xinfeng Bai, Jianhui Zhang, Shuzhen Liu, Zekun Sun, Xinying Cao, Jianping Wang, Ying Zhang, Boqing Li and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Pathogenicity ofWorld journal of clinical oncology · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Huilin Zhao *Department of Pathogenic Biology, School of Basic Medical Sciences, Binzhou Medical University, Yantai, China.
Si Chen *Department of Pathogenic Biology, School of Basic Medical Sciences, Binzhou Medical University, Yantai, China.
Xinfeng Bai *Translational Medicine Research Center, Shandong Provincial Third Hospital, Shandong University, Jinan, China.
Jianhui ZhangDepartment of Pathogenic Biology, School of Basic Medical Sciences, Binzhou Medical University, Yantai, China.
Shuzhen LiuDepartment of Pathogenic Biology, School of Basic Medical Sciences, Binzhou Medical University, Yantai, China.
Zekun SunDepartment of Pathogenic Biology, School of Basic Medical Sciences, Binzhou Medical University, Yantai, China.
Xinying CaoThe Second School of Clinical Medicine, Binzhou Medical University, Yantai, China.
Jianping WangTranslational Medicine Research Center, Shandong Provincial Third Hospital, Shandong University, Jinan, China.
Ying ZhangDepartment of Pathogenic Biology, School of Basic Medical Sciences, Binzhou Medical University, Yantai, China.
Boqing LiDepartment of Pathogenic Biology, School of Basic Medical Sciences, Binzhou Medical University, Yantai, China.
Xiaofei JiXu Rongxiang Regenerative Medicine Research Center, Binzhou Medical University, Yantai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growth factor receptor bound protein 7 (GRB7) is reportedly upregulated in human gastric cancer (GC), which is closely associated with tumor progression and prognosis. However, the mechanism underlying its dysregulation in GC remains poorly understood. In this study, we found that GRB7 overexpression was associated with

Indexed as

CagAgastric cancerGRB7Helicobacter pyloriSTAT3

Identifiers

PMID39360313
PMCPMC11444978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.